The officer's repeated monthly sales pattern suggests routine option exercise and monetization rather than a one-time event. Monitor for any acceleration in selling volume ahead of upcoming catalysts (e.g., clinical data readouts or earnings).
Price Chart
Executive Summary
Officer David Malcom Rodman filed a Form 144 notice to sell 3,542 shares of Mineralys Therapeutics common stock, valued at approximately $78,066, via a cashless exercise of employee stock options. The filing also discloses a pattern of prior sales totaling over 50,000 shares since July 2026, suggesting ongoing insider monetization of equity compensation.
Key Facts
- Insider: David Malcom Rodman (Officer)
- Proposed sale: 3,542 shares of common stock
- Estimated value: $78,065.68
- Sale method: Cashless exercise of employee stock options via broker Merrill Lynch
- Filing date: October 13, 2026
- Prior sales by same insider: 10 transactions from July to September 2026 totaling ~50,000+ shares
Financial Impact
Proposed sale of $78,066 in common stock; cumulative insider sales since July 2026 exceed $1.3 million
Risk Factors
- Continued insider selling could signal lack of confidence or simply compensation diversification
- Cashless exercise does not require insider to put up capital, reducing signaling value
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001964306-26-000466 |
| Document: 0001964306-26-000466-index.html | 0001964306-26-000466 |
| Document: 0001964306-26-000466.txt | 0001964306-26-000466 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 today | Press Release | $20.59 | awaiting T+20 | awaiting T+20 | $21.38 (+3.84%) |
Oct 20, 2026 8d ago | 3 | $21.10 | awaiting T+20 | awaiting T+20 | $21.38 (+1.33%) |
Oct 20, 2026 8d ago | 3 | $21.10 | awaiting T+20 | awaiting T+20 | $21.38 (+1.33%) |
Oct 19, 2026 9d ago | 8-K | $21.58 | awaiting T+20 | awaiting T+20 | $21.38 (−0.93%) |
Oct 13, 2026 15d ago | 144 | $20.76 | awaiting T+20 | awaiting T+20 | $21.38 (+2.99%) |
Sep 30, 2026 28d ago | 144 | $23.72 | awaiting T+20 | awaiting T+20 | $21.38 (−9.87%) |
Sep 29, 2026 29d ago | Press Release | $25.13 $21.13 | ▼ −15.92% | ▼ −16.84% | $21.38 (−14.92%) |
Sep 24, 2026 4w ago | Insider Cluster | $25.86 $20.55 | ▲ +20.53% | ▲ +19.06% | $21.38 (+17.32%) |
Sep 22, 2026 5w ago | Insider Cluster | $26.89 $21.10 | ▼ −21.53% | ▼ −22.22% | $21.38 (−20.49%) |
Aug 12, 2026 11w ago | 3 | $26.09 $28.20 | ▲ +8.09% | ▲ +9.83% | $21.38 (−18.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers